A series of new studies have revealed signs of strong and lasting immunity in people who developed a mild coronavirus infection, according to a report on Sunday.The studies, which have yet to be peer-reviewed, uncovered that antibodies and immune cells capable of recognizing the virus were apparently present months after infections concluded. The findings could help to eliminate the previous concerns…
Researchers have been investigating how long antibodies to the coronavirus last in people who have recovered from infections. Simon Dawson/AP hide caption toggle caption Simon Dawson/AP Researchers have been investigating how long antibodies to the coronavirus last in people who have recovered from infections. Simon Dawson/AP So many people are counting on a vaccine to…
New research suggests that antibodies the immune system makes to fight the new coronavirus may only last a few months in people with mild illness, but that doesn’t mean protection also is gone or that it won’t be possible to develop an effective vaccine.“Infection with this coronavirus does not necessarily generate lifetime immunity,” but antibodies…
A woman in a protective face mask walks through Brixton Market in South London, as the UK continues in lockdown to help curb the spread of the coronavirus.Victoria Jones | PA Images via Getty ImagesImmunity to Covid-19 might only last a few months, according to a U.K. study that casts doubts over the longevity of…
(Oona Zenda/KFF Health News) As Grace Griffin and her husband were welcoming their long-awaited baby — a daughter — Griffin found herself worried about looming medical bills and unsure if their family could pay for the care they needed. “This whole experience has me wondering (keeping me up at night, actually): Can we ever afford
LYON, France — Halving the dose of antenatal betamethasone given to prevent severe respiratory distress syndrome (RDS) in infants does not appear to affect later intelligence quotient (IQ) scores or other measures of neurodevelopment, suggests a follow-up study of a randomized trial. However, it is unclear from the present data, presented at the Congress of
After years of searching for affordable health insurance, Trey Wright discovered Georgia Pathways to Coverage. The state’s limited Medicaid expansion program allowed the 27-year-old living in the rural city of Jesup in southeastern Georgia to finally visit a primary care doctor regularly. It also covered weekly shots to manage an array of allergies, saving him